p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding

Nature Structural and Molecular Biology

Volumn 11, Issue 4, 2004, Pages 358-364

  Lacy, Eilyn R ^a   Filippov, Igor ^a,d   Lewis, William S ^a   Otieno, Steve ^a,b   Xiao, Limin ^a   Weiss, Sonja ^c   Hengst, Ludger ^c   Kriwacki, Richard W ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^d Department of Chemistry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE; PROTEIN P27; PROTEIN P57;

ARTICLE; CELL CYCLE; COMPLEX FORMATION; HUMAN; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM;

AMINO ACID SEQUENCE; CDC2-CDC28 KINASES; CONSERVED SEQUENCE; CYCLIN-DEPENDENT KINASE 2; CYCLINS; HUMANS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MICROFILAMENT PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; PROTEIN CONFORMATION; PROTEIN FOLDING; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SOLUTIONS; THERMODYNAMICS;

EID: 1842473094     PISSN: 15459993     EISSN: None     Source Type: Journal    
DOI: 10.1038/nsmb746     Document Type: Article

References (53)

1. Hengst, L., Dulic, V., Slingerland, J.M., Lees, E. & Reed, S.I. A cell cycle-regulated inhibitor of cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91, 5291-5295 (1994).
2. Polyak, K. et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66 (1994).
3. Toyoshima, H. & Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74 (1994).
4. Gu, Y., Turck, C.W. & Morgan, D.O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366, 707-710 (1993).
5. El-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
6. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. & Elledge, S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816 (1993).
7. Xiong, Y. et al. p21 is a universal inhibitor of cyclin kinases. Nature 366, 701-704 (1993).
8. Noda, A., Ning, Y., Venable, S.F., Pereira-Smith, O.M. & Smith, J.R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211, 90-98 (1994),
9. Morgan, D.O. Principles of CDK regulation. Nature 374, 131-134 (1995).
10. Lee, M.H., Reynisdóttir, I. & Massagué, J. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9, 639-649 (1995).
11. Matsuoka, S. et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9, 650-662 (1995).
12. Harper, J.W. et al. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6, 387-400 (1995).
13. Baus, F., Gire, V., Fisher, D., Piette, J. & Dulic, V. Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts. EMBO J. 22, 3992-4002 (2003).
14. van den Heuvel, S. & Harlow, E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262, 2050-2054 (1993).
15. Morgan, D.O. Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu. Rev. Cell Dev. Biol. 13, 261-291 (1997),
16. Kriwacki, R.W., Hengst, L., Tennant, L., Reed, S.I. & Wright, P.E. Structural studies of p21(waf1/cip1/sdi1) in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. USA 93, 11504-11509 (1996).
17. Bienkiewicz, E.A., Adkins, J.N. & Lumb, K.J. Functional consequences of preorganized helical structure in the intrinsically disordered cell-cycle inhibitor p27(Kip1). Biochemistry 41, 752-759 (2002).
18. Russo, A.A., Jeffrey, P.D., Patten, A.K., Massague, J. & Pavletich, N.P. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 382, 325-331 (1996).
19. Wright, P.E. & Dyson, H.J. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 293, 321-331 (1999).
20. Dunker, A.K. & Obradovic, Z. The protein trinity-linking function and disorder. Nat, Biotechnol, 19, 805-806 (2001).
21. Adkins, J.N. & Lumb, K.J. Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2. Proteins 46, 1-7 (2002).
22. Tompa, P. Intrinsically unstructured proteins. Trends Biochem. Sci. 27, 527-533 (2002).
23. Schwarzinger, S. et al. Sequence-dependent correction of random coil NMR chemical shifts. J. Am. Chem. Soc. 123, 2970-2978 (2001).
24. Wishart, D.S. & Sykes, B.D. Chemical shifts as a tool for structure determination. Methods Enzymol. 239, 363-392 (1994).
25. Kay, L.E. Protein dynamics from NMR. Nat. Struct. Biol. 5 (Suppl.), 513-517 (1998).
26. Spolar, R.S. & Record, M.T.J. Coupling of local folding to site-specific binding of proteins to DNA. Science 263, 777-784 (1994).
27. Pavletich, N.P. Mechanisms of cyclin-dependent kinase regulation: Structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J. Mol. Biol. 287, 821-828 (1999).
28. Jeffrey, P.D. et al. Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature 376, 313-320 (1995).
29. Koshland, D.E.J. Application of a theory of enzyme specificity to protein synthesis. Proc. Natl. Acad. Sci. USA 44, 98-104 (1958).
30. Schulman, B.A., Lindstrom, D.L. & Harlow, E. Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc. Natl. Acad. Sci. USA 95, 10453-10458 (1998).
31. Brown, N.R., Noble, M.E., Endicott, J.A. & Johnson, L.N. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat. Cell Biol. 1, 438-443 (1999).
32. Kim, K.K., Chamberlin, H.M., Morgan, D.O. & Kim, S.H. Three-dimensional structure of human cyclin H, a positive regulator of the CDK-activating kinase. Nat. Struct. Biol. 3, 849-855 (1996).
33. nCk5a complex. Mol. Cell 8, 657-669 (2001).
34. Tanaka, H. et al. Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity. J. Cell Biol. 158, 321-329 (2002).
35. Huang, S. et al. Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). Mol. Cell 11, 1491-1501 (2003).
36. Shim, J., Lee, H., Park, J., Kim, H. & Choi, E.J. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 381, 804-806 (1996).
37. Suzuki, A., Tsutomi, Y., Akahane, K., Araki, T. & Miura, M. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 17, 931-939 (1998).
38. Suzuki, A., Tsutomi, Y., Miura, M. & Akahane, K. Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21. Oncogene 18, 1239-1244 (1999).
39. Suzuki, A. et al. Procaspase 3/p21 complex formation to resist Fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A. Cell Death Differ. 7, 721-728 (2000).
40. Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J. Biol. Chem. 277, 28706-28713 (2002).
41. Studier, F.W., Rosenberg, A.H., Dunn, J.J. & Dubendorff, J.W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185, 60-89 (1990).
42. Edelhoch, H. Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 6, 1948-1954 (1967).
43. Gill, S.C. & von Hippel, P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182, 319-326 (1989).
44. Neidhardt, F.C., Bloch, P.L. & Smith, D.F. Culture medium for enterobacteria. J. Bacteriol. 119, 736-747 (1974).
45. 2H-labeled proteins: application to a 37-kDa Trp repressor-DNA complex. J. Am. Chem. Soc. 116, 6464-6465 (1994).
46. 2H labeled proteins with high sensitivity. J. Am. Chem. Soc. 116, 11655-11666 (1994).
47. Delaglio, F. et al. NMR Pipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293 (1995).
48. Cavanagh, J., Fairbrother, W.J., Palmer, A.G. III & Skelton, N.J. Protein NMR Spectroscopy (Academic, New York, 1996).
49. Morton, T.A. & Myszka, D.G. Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Methods Enzymol. 295, 268-294 (1998).
50. Rost, B. PHD: predicting one-dimensional protein structure by profile-based neural networks. Methods Enzymol. 266, 525-539 (1996).
51. Nicholls, A., Sharp, K.A. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281-296 (1991).
52. Kriwacki, R.W., Wu, J., Siuzdak, G. & Wright, P.E. Probing protein/protein interactions with mass spectrometry and isotopic labeling: analysis of the p21/Cdk2 complex. J. Am. Chem. Soc. 118, 5320-5321 (1996).
53. Kriwacki, R.W., Wu, J., Tennant, L., Wright, P.E. & Siuzdak, G. Probing protein structure using biochemical and biophysical methods. Proteolysis, matrix-assisted laser desorption/ionization mass spectrometry, high-performance liquid chromatography and size-exclusion chromatography of p21Waf1/Cip1/Sdi1. J. Chromatogr. A 777, 23-30 (1997).